Clinical Trial Update: Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial update of ticagrelor with aspirin or alone in high-risk patients after coronary intervention; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Cardiovascular Disease, Interventional Cardiology | Phase 4 | Status: COMPLETED | Results posted: 2020-08-19